BioSpace News Archive

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXI

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will hold a series of virtual deep dive webinars discussing its therapeutic platforms and programs. The first webinar in the series will discuss its Bio-e platform on Friday, June 5 at 10:00 a.m. ET . The Bio-e platform deep dive will provide an overview of the

Leading healthcare technology company jumps nearly 50 spots in prestigious listing of publicly traded companies

Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its next generation Sonata® System 2.1 for Transcervical Fibroid Ablation (TFA). The Sonata techno

Genome BC is pleased to announce $1 million in funding to Sonic Incytes Medical Corp., completing the company’s seed financing round of over CDN$3.5 million supported by institutional investors, angel funds and private individuals.

I-MED Pharma Inc., a Canadian medical device company, announced today that it is collaborating with KMG International Limited to manufacture and supply personal protective equipment (PPE) and COVID-19 diagnostic tests to help respond to the urgent need for these products in Canada, the United States, and Europe.

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced that Bill Rasmussen has joined its team to help speed a cure for Parkinson’s disease.

POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced that members of the Poxel management team will participate in several upcoming virtual investor conferences held in June 2020. Jefferies Virtual Healthcare Conference 2020 Date: June 2-

New research published today in the Journal of NeuroInterventional Surgery (JNIS) shows ischemic stroke patients are arriving to hospitals and treatment centers an average of 160 minutes later during the COVID-19 pandemic, as compared with a similar timeframe in 2019

Premier Inc., through its ProvideGx™ program, has partnered with Hikma Pharmaceuticals PLC to supply amiodarone and sterile water to healthcare providers, helping to stabilize the long-term supply of two medications vital for COVID-19 patient care.